Accustem Sciences Inc.

Biotechnology • Healthcare • New York, NY, United States • ACUT (OQB)

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-invasive blood testing technologies. AccuStem Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.

5 Penn Plaza, New York, NY 10001, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

AccuStem to launch MSC blood test for lung cancer screening in US - Medical Device Network

Medical Device Network • Apr 7

AccuStem Share Price - ACUT, RNS News, Articles, Quotes, & Charts (OTCMKTS:ACUT) - Proactive Investors

Proactive Investors • Jun 8

Vocxi Health Prepares for Commercialization of Breath Test for Lung Cancer - 360Dx

360Dx • Mar 26

Abbott's iStat Comes Out on Top in Study Comparing Blood Clot Monitoring Tests - 360Dx

360Dx • May 16

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Accustem Sciences Inc. had layoffs?

No layoff events have been recorded for Accustem Sciences Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Accustem Sciences Inc. have?

Accustem Sciences Inc. has approximately 2 employees.

What industry is Accustem Sciences Inc. in?

Accustem Sciences Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Accustem Sciences Inc. a publicly traded company?

Yes, Accustem Sciences Inc. is publicly traded under the ticker symbol ACUT on the OQB. The company has a market capitalization of approximately $0.01 billion.

Where is Accustem Sciences Inc. headquartered?

Accustem Sciences Inc. is headquartered in New York, NY, United States at 5 Penn Plaza, New York, NY 10001, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.